Noah Berkowitz, M.D., Ph.D.

Dr. Berkowitz is vice president and therapeutic area head of hematology/oncology at Novartis. Prior to Novartis, Dr. Berkowitz was a senior medical director at Enzon Pharmaceuticals where he was a clinical leader for the cytotoxic chemotherapy and antisense technology programs. As a physician-scientist, drug and molecular diagnostic developer, he holds 20 years of leadership experience in targeted drug development in oncology and cardiovascular disease. Dr. Berkowitz earned his B.A., M.D., and Ph.D. from Columbia University and trained at the National Cancer Institute in medical oncology.